DCOY CIK: 1615219

Decoy Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.2
FY22:
−17.6
FY23:
−12.8
FY24:
−4.53
FY25:
−4.83
millions USD
FY21:
0
FY22:
−1.50
FY23:
0
FY24:
0
FY25:
0.76
Change from FY21 to FY25
millions USD
FY21:
28.3
FY22:
1.99
FY23:
6.64
FY24:
1.06
FY25:
12.3
millions USD
FY21:
18.1
FY22:
−17.1
FY23:
−6.21
FY24:
−3.47
FY25:
8.28
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.2
FY22:
–
FY23:
–
FY24:
−4.53
FY25:
−5.40

All amounts in millions USD Data source:SEC EDGAR